Depression, anxiety, chronic pain, fibromyalgia, neuropathy and hot flashes are some of the many issues Cymbalta helps you tackle. The cost, however, has been a real issue for patients. Now, you’re good.
The Food and Drug Administration (FDA) has approved the first generic versions of Cymbalta, duloxetine delayed-release capsules. Several different drug companies had their generic versions accepted so there will be many folks making duloxetine; this should lower the cost quite a bit. As with all generics, the FDA has assured healthcare professionals and consumers that these generic versions have met rigorous standards on their way to approval. This means you should be able to switch from brand name to generic with no problem.
Who shouldn’t take Cymbalta or duloxetine? Duloxetine will carry the same black box warning as Cymbalta: there have been reports of increased risk of suicidal thinking and behaviour during initial treatment in children, adolescents, and young adults aged 18 to 24 years. Along with that warning comes the reassuring data that folks over 24 do not have the same issue, and that in fact patients 65 years and older who take antidepressants have a decreased risk of suicidal thinking and behaviour.
Cymbalta, and now its generic form duloxetine, may cause nausea, dry mouth and drowsiness, but if you’ve been on the brand name paying that money—well now you’re in luck. Duloxetine will be much cheaper.